Stock Evaluator: SI-BONE, Inc. (SIBN)

SI-BONE, Inc. SIBN

$18.63 -0.53 -2.77%
September 3, 2026 10:45:24 AM EST November 10, 2021 Volume: 140,968
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Commentary & Analysis


Financial Summary

Share Statistics SIBN Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $859.2 $416.1 43%
Shares Out (Mil) 44.5 41.6 45%
Institutional Ownership 96.8% 83.1% 71%
Float (Mil) 40.0 35.6 42%
Beta 0.70 0.88 41%
Avg Daily Volume (000s) 631 333 64%
Price Change
(52-week)
16.5% 65.0% 61%
Growth SIBN Industry
Median
Percentile
(All Stocks)
Sales (5yr) 22.3% 11.8% 84%
Net Income (5yr) 15.4% (5.9%) 64%
EPS (5yr) 21.8% 10.2% 71
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (35.1%) (15.6%) 15%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 8 8 8
Current EPS ($0.128) ($0.397) ($0.331)
Month Ago EPS ($0.124) ($0.424) ($0.344)
# Rev Up 0 0 2
# Rev Down 0 1 1
Three Months Ago EPS ($0.130) ($0.429) ($0.353)
Year/Year Chg 39.1% (9.8%) (63.9%)
Financials SIBN Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $214 $119 32%
Net Income (TTM) (Mil) ($15) ($9) 26%
EPS (TTM) ($0.334) ($0.400) 30%
Operating Cash Flow (TTM) (Mil) $3 ($3) 34%
Net Cash Flow (TTM) (Mil) ($1) $1 40%
Long-Term Debt (Q1) (Mil) $42 $22 38%
Enterprise Value (Q1) (Mil) $705 $371 37%
Valuation SIBN Industry
Median
Percentile
(All Stocks)
P/B 4.70 3.00 77%
P/E na 27.8 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.6 na
Ratios SIBN Industry
Median
Percentile
(All Stocks)
Gross Margin 79.5% 58.5% 88%
Net Margin (6.9%) (6.9%) 23%
ROA (6.1%) (13.4%) 29%
ROE (8.3%) (13.6%) 29%
Liabilities to Assets 26.7% 46.1% 18%
F-Score 6 4 67%

SI-BONE, Inc. did not pass any screens on 9/2/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors